Search Results
Immunotherapy: PD-1 Antibodies and Beyond- Dr. Carvajal Melanoma Education Symposium 2014
Immunotherapy - PD-1 and Beyond - Melanoma Education Symposium, Patrick Ott MD PhD
Response to Targeted and Immunotherapy through Biopsy- Dr. Wargo Melanoma Education Symposium 2014
Welcome: Keynote - Dr. Piro Melanoma Education Symposium 2014
Immunotherapy for Metastatic Melanoma — PD-1 Clinical Trials
Immunotherapy Success and Approvals — PD-1 Inhibitors
Manipulating the Tumor and the Immune System: Lessons Learned in Melanoma and Beyond
Anti- PD1 Treatment in Advanced Melanoma
Dr. Kluger on the Difference Between Blocking PD-1 and PD-L1 in Melanoma
PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma
Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma
The Development of Therapies in Metastatic Melanoma- Dr. Patel Melanoma Education Symposium 2014
